Table 1.
Baseline characteristics of the volunteers at each of the visits.
Visit 1 | Visit 2 | Visit 3 | |
---|---|---|---|
Weight (kg) | 65.9 ± 10.1 | 66.1 ± 9.7 | 66.3 ± 9.8 |
Height (m) | 1.69 ± 0.09 | 1.69 ± 0.09 | 1.69 ± 0.09 |
BMI (kg/m2) | 23.13 ± 2.96 | 23.19 ± 2.90 | 23.28 ± 3.08 |
Waist (cm) | 75.2 ± 8.4 | 75.5 ± 7.3 | 75.2 ± 7.7 |
Hip (cm) | 98.1 ± 6.9 | 98.2 ± 6.6 | 98.1 ± 6.8 |
Waist to hip ratio | 0.77 ± 0.07 | 0.77 ± 0.06 | 0.77 ± 0.06 |
Systolic BP (mmHg) | 116 ± 8 | 114 ± 7 | 115 ± 9 |
Diastolic BP (mmHg) | 71 ± 6 | 72 ± 6 | 71 ± 6 |
tCys (μmol/L) | 260 ± 27 | 261 ± 25 | 260 ± 26 |
tHCys (μmol/L) | 9.9 ± 4.7 | 9.3 ± 3.9 | 9.5 ± 4.0 |
tCysGly (μmol/L) | 32.8 ± 6.4 | 29.5 ± 5.3 | 30.4 ± 6.6 |
tGSH (μmol/L) | 8.9 ± 2.6 | 7.4 ± 1.4 | 7.4 ± 1.8 |
Glucose (mmol/L) | 4.7 ± 0.3 | 4.8 ± 0.4 | 4.8 ± 0.4 |
Insulin (pmol/L) | 52.1 ± 14.1 | 55.0 ± 16.4 | 58.0 ± 18.4 |
Uric acid (mmol/L) | 0.26 ± 0.06 | 0.26 ± 0.05 | 0.26 ± 0.08 |
Characterization of the participants that completed the full three visits (n = 38), with data presented for each visit as the mean ± standard deviation (SD). Values were not significantly different between visits (p > 0.05; parametric ANOVA with repeated measures). Data in fasting plasma are comparable to published values (μmol/L): Cys: 219 ± 1462; 256 ± 1763; 321 ± 5064; for HCys: 9.5 ± 0.462; 9.9 ± 2.465 ; 14.1 ± 4.964; for CysGly: 24.4 ± 4.564; 39.7 ± 4.962; for GSH: 2–2066; 5.69 ± 1.3364; 9.07 ± 1.5562. t = total. BP, blood pressure.